Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation - PubMed (original) (raw)
Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation
J Campisi et al. Cell. 1984 Feb.
Abstract
Cellular oncogenes are DNA sequences implicated in the genesis of cancer, but their functions in the transformation process are not understood. Our experiments provide data linking expression of two well-studied proto-oncogenes, c-myc and c-rasKi, to current knowledge of proliferation control and its perturbation by differentiation and chemical transformation. Growth stimulation of quiescent cells by serum elevates expression of the myc proto-oncogene in Balb/c 3T3 (A31) cells. In two chemically transformed A31 derivatives (BPA31 and DA31), c-myc expression is constitutive. The levels of c-myc mRNA in quiescent and growing transformed cells are nearly the same, and are only slightly elevated compared to the level found in growing A31 cells. By contrast, c-rasKi expression is cell-cycle-dependent in BPA31 cells. The relative abundance of c-rasKi mRNA begins to increase in mid- to late G0/G1. During terminal differentiation of teratocarcinoma stem cells (F9) into nonproliferating endoderm, relative mRNA abundance is diminished more markedly for c-myc than for c-rasKi. These results demonstrate that expression of the myc and rasKi proto-oncogenes is dependent upon the cellular growth state, and that growth control exhibits growth-factor-dependent, cell-cycle-timed oncogene expression. In the case of the BPA31 cells, c-myc is not rearranged, amplified, or overexpressed. However, the oncogene has lost its cycle-dependent regulation in the chemically transformed cells.
Similar articles
- Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells.
Persson H, Gray HE, Godeau F. Persson H, et al. Mol Cell Biol. 1985 Nov;5(11):2903-12. doi: 10.1128/mcb.5.11.2903-2912.1985. Mol Cell Biol. 1985. PMID: 3915769 Free PMC article. - Altered regulation of c-myc expression in adenovirus-transformed cells.
Braithwaite AW, Fry KE, LeJeune S, Naora H. Braithwaite AW, et al. Can J Genet Cytol. 1986 Oct;28(5):712-24. doi: 10.1139/g86-101. Can J Genet Cytol. 1986. PMID: 3801968 - Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact.
Dean M, Levine RA, Ran W, Kindy MS, Sonenshein GE, Campisi J. Dean M, et al. J Biol Chem. 1986 Jul 15;261(20):9161-6. J Biol Chem. 1986. PMID: 3722193 - Neoplastic transformation of 3T3 mouse embryo cells with c-myc- and c-Ha-ras-1 oncogenes.
Armelin HA, Armelin MC, Kovary K. Armelin HA, et al. Braz J Med Biol Res. 1988;21(6):1155-61. Braz J Med Biol Res. 1988. PMID: 3074839 Review. - Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA, Hoffman B. Liebermann DA, et al. Stem Cells. 1994 Jul;12(4):352-69. doi: 10.1002/stem.5530120402. Stem Cells. 1994. PMID: 7951003 Review.
Cited by
- Ras proteins are essential and selective for the action of insulin-like growth factor 1 late in the G1 phase of the cell cycle in BALB/c murine fibroblasts.
Lu K, Campisi J. Lu K, et al. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3889-93. doi: 10.1073/pnas.89.9.3889. Proc Natl Acad Sci U S A. 1992. PMID: 1570309 Free PMC article. - Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11.
Mason IJ, Murphy D, Münke M, Francke U, Elliott RW, Hogan BL. Mason IJ, et al. EMBO J. 1986 Aug;5(8):1831-7. doi: 10.1002/j.1460-2075.1986.tb04434.x. EMBO J. 1986. PMID: 3758028 Free PMC article. - Activation of c-myb expression by phytohemagglutinin stimulation in normal human T lymphocytes.
Torelli G, Selleri L, Donelli A, Ferrari S, Emilia G, Venturelli D, Moretti L, Torelli U. Torelli G, et al. Mol Cell Biol. 1985 Oct;5(10):2874-7. doi: 10.1128/mcb.5.10.2874-2877.1985. Mol Cell Biol. 1985. PMID: 3915538 Free PMC article. - Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene.
Larsson LG, Ivhed I, Gidlund M, Pettersson U, Vennström B, Nilsson K. Larsson LG, et al. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2638-42. doi: 10.1073/pnas.85.8.2638. Proc Natl Acad Sci U S A. 1988. PMID: 3357885 Free PMC article. - Immortalization by c-myc, H-ras, and Ela oncogenes induces differential cellular gene expression and growth factor responses.
Kelekar A, Cole MD. Kelekar A, et al. Mol Cell Biol. 1987 Nov;7(11):3899-907. doi: 10.1128/mcb.7.11.3899-3907.1987. Mol Cell Biol. 1987. PMID: 2963209 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous